Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 7378148, 13 pages
https://doi.org/10.1155/2017/7378148
Research Article

miR-195-5p Suppresses the Proliferation, Migration, and Invasion of Oral Squamous Cell Carcinoma by Targeting TRIM14

1Medical College, Nankai University, Tianjin 300070, China
2Department of Oral and Maxillofacial Surgery, Chinese PLA General Hospital, Beijing 100853, China
3Department of Oral and Maxillofacial Surgery, Tianjin Stomatology Hospital, Tianjin 300041, China

Correspondence should be addressed to Lei Zhang; moc.361@latnedko and Rongfa Bu; moc.nuyila@ubafgnor

Received 30 June 2017; Revised 10 September 2017; Accepted 18 September 2017; Published 24 October 2017

Academic Editor: Takashi Saku

Copyright © 2017 Tong Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Wang, S. Zhang, K. Yue, and X.-D. Wang, “The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases,” Chinese Journal of Cancer, vol. 32, no. 11, pp. 614–618, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Pérez-Sayáns, J. M. Suárez-Peñaranda, M. E. Padín-Iruegas et al., “The Loss of p16 Expression Worsens the Prognosis of OSCC,” Applied Immunohistochemistry & Molecular Morphology, vol. 23, no. 10, pp. 724–732, 2015. View at Publisher · View at Google Scholar
  3. Y. Wang, C. Sun, T. Li et al., “Integrative approach detected association between genetic variants of microRNA binding sites of TLRs pathway genes and OSCC susceptibility in Chinese Han population,” PLoS ONE, vol. 9, no. 7, Article ID e101695, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Benderska, A.-L. Dittrich, S. Knaup et al., “MiRNA-26b overexpression in ulcerative colitis-associated carcinogenesis,” Inflammatory Bowel Diseases, vol. 21, no. 9, pp. 2039–2051, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Bucay, V. Shahryari, S. Majid et al., “miRNA expression analyses in prostate cancer clinical tissues,” Journal of Visualized Experiments, vol. 2015, no. 103, Article ID e53123, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Butz, P. M. Szabó, H. W. Z. Khella, R. Nofech-Mozes, A. Patocs, and G. M. Yousef, “miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1,” Oncotarget , vol. 6, no. 14, pp. 12543–12557, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Chacon-Cortes, R. A. Smith, L. M. Haupt, R. A. Lea, P. H. Youl, and L. R. Griffiths, “Genetic association analysis of miRNA SNPs implicates MIR145 in breast cancer susceptibility,” BMC Medical Genetics, vol. 16, no. 1, article no. 107, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Chen and B. Liu, “MiRNA-381 inhibits the invasion of renal carcinoma and the underlying mechanisms,” Zhong Nan Da Xue Xue Bao Yi Xue Ban, vol. 40, no. 10, pp. 1053–1059, 2015. View at Google Scholar
  9. C. Liu, Z. Wang, Y. Wang, and W. Gu, “miR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1,” Molecular and Cellular Biochemistry, vol. 398, no. 1-2, pp. 115–122, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. X.-C. Wang, Y. Ma, P.-S. Meng, J.-L. Han, H.-Y. Yu, and L.-J. Bi, “MiR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6,” Oral Oncology, vol. 51, no. 7, pp. 674–682, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Shao, Y. Qu, S. Dang, B. Yao, and M. Ji, “MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6,” Cancer Cell International, vol. 13, no. 1, article 51, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. Li, H. Wang, Z. Wang, and H. Cai, “MiR-195 inhibits the proliferation of human cervical cancer cells by directly targeting cyclin D1,” Tumor Biology, vol. 37, no. 5, pp. 6457–6463, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Liu, J. Qu, F. Xu et al., “MiR-195 suppresses non-small cell lung cancer by targeting CHEK1,” Oncotarget , vol. 6, no. 11, pp. 9445–9456, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Liu, H. Guan, Y. Wang et al., “MIR-195 inhibits emt by targeting FGF2 in prostate cancer cells,” PLoS ONE, vol. 10, no. 12, Article ID e0144073, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. L.-F. Jia, S.-B. Wei, K. Gong, Y.-H. Gan, and G.-Y. Yu, “Prognostic Implications of MicoRNA miR-195 Expression in Human Tongue Squamous Cell Carcinoma,” PLoS ONE, vol. 8, no. 2, Article ID e56634, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Alloush and N. Weisleder, “TRIM proteins in therapeuticmembrane repair ofMuscular dystrophy,” JAMA Neurology, vol. 70, no. 7, pp. 928–931, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Kimura, A. Jain, S. W. Choi et al., “TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity,” The Journal of Cell Biology, vol. 210, no. 6, pp. 973–989, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Tocchini and R. Ciosk, “TRIM-NHL proteins in development and disease,” Seminars in Cell & Developmental Biology, vol. 47-48, pp. 52–59, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Tomar and R. Singh, “TRIM family proteins: Emerging class of RING E3 ligases as regulator of NF-κB pathway,” Biology of the Cell, vol. 107, no. 1, pp. 22–40, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. V. V. Nenasheva, G. V. Kovaleva, N. V. Khaidarova et al., “Trim14 overexpression causes the same transcriptional changes in mouse embryonic stem cells and human HEK293 cells,” In Vitro Cellular & Developmental Biology - Animal, vol. 50, no. 2, pp. 121–128, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. V. V. Nenasheva, G. V. Kovaleva, L. V. Uryvaev et al., “Enhanced expression of trim14 gene suppressed Sindbis virus reproduction and modulated the transcription of a large number of genes of innate immunity,” Immunologic Research, vol. 62, no. 3, pp. 255–262, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Xu, Z. Zhou, R. Dudley et al., “An integrative approach to understanding bird origins,” Science, vol. 346, no. 6215, Article ID 1253293, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Chen, J. Zhou, X. Chen et al., “miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2,” Tumor Biology, vol. 36, no. 10, pp. 8221–8229, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. W.-S. Chen, C.-J. Yen, Y.-J. Chen et al., “miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin,” Oncotarget , vol. 6, no. 28, pp. 25962–25974, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. B. S. Comer, “Does miRNA-155 Promote Cyclooxygenase-2 Expression in Cancer?” Drug Development Research, vol. 76, no. 7, pp. 354–356, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. S.-J. Fan, H.-B. Li, G. Cui et al., “MIRNA-149* promotes cell proliferation and suppresses apoptosis by mediating JunB in T-cell acute lymphoblastic leukemia,” Leukemia Research, vol. 41, pp. 62–70, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Dai, X. Wang, X. Li, and Y. Cao, “MicroRNA-139-5p acts as a tumor suppressor by targeting ELTD1 and regulating cell cycle in glioblastoma multiforme,” Biochemical and Biophysical Research Communications, vol. 467, no. 2, pp. 204–210, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Li, G. Dong, B. Wang, W. Gao, and Q. Yang, “MiR-543 promotes gastric cancer cell proliferation by targeting SIRT1,” Biochemical and Biophysical Research Communications, vol. 469, no. 1, pp. 15–21, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. K.-W. Chang, S.-Y. Kao, Y.-H. Wu et al., “Passenger strand miRNA miR-31 regulates the phenotypes of oral cancer cells by targeting RhoA,” Oral Oncology, vol. 49, no. 1, pp. 27–33, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. J. P. S. Chawla, N. Iyer, K. S. Soodan, A. Sharma, S. K. Khurana, and P. Priyadarshni, “Role of miRNA in cancer diagnosis, prognosis, therapy and regulation of its expression by Epstein-Barr virus and human papillomaviruses: With special reference to oral cancer,” Oral Oncology, vol. 51, no. 8, pp. 731–737, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Ren, H. Zhu, C. Chi, F. Yang, and X. Xu, “MiRNA-139 regulates oral cancer Tca8113 cells apoptosis through Akt signaling pathway,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 5, pp. 4588–4594, 2015. View at Google Scholar · View at Scopus
  32. F. Wang, C. Jiang, Q. Sun et al., “miR-195 is a key regulator of Raf1 in thyroid cancer,” OncoTargets and Therapy, vol. 8, pp. 3021–3028, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Wang, J. Zhang, and L. Tong, “miR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 11, pp. 14110–14120, 2015. View at Google Scholar · View at Scopus
  34. S. Y. Susluer, C. B. Avci, Y. Dodurga, Z. O. D. Sigva, N. Oktar, and C. Gunduz, “Downregulation of miR-195 via cyclosporin a in human glioblastoma cells,” Journal of B.U.ON., vol. 20, no. 5, pp. 1337–1340, 2015. View at Google Scholar · View at Scopus
  35. L. Li, C. Li, S. Wang et al., “Exosomes derived from hypoxic oral squamous cell carcinoma cells deliver miR-21 to normoxic cells to elicit a prometastatic phenotype,” Cancer Research, vol. 76, no. 7, pp. 1770–1780, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. S. He, R. Lai, D. Chen et al., “Downregulation of MIR-221 inhibits cell migration and invasion through targeting methyl-CpG binding domain protein 2 in human oral squamous cell carcinoma cells,” BioMed Research International, vol. 2015, Article ID 751672, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. C.-M. Cheng, S.-G. Shiah, C.-C. Huang, J.-R. Hsiao, and J.-Y. Chang, “Up-regulation of miR-455-5p by the TGF-β–SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B,” The Journal of Pathology, vol. 240, no. 1, pp. 38–49, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Zhu, Q. Ye, L. Chang, W. Xiong, Q. He, and W. Li, “Upregulation of miR-195 enhances the radiosensitivity of breast cancer cells through the inhibition of BCL-2,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 6, pp. 9142–9148, 2015. View at Google Scholar
  39. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Lagos-Quintana, R. Rauhut, W. Lendeckel, and T. Tuschl, “Identification of novel genes coding for small expressed RNAs,” Science, vol. 294, no. 5543, pp. 853–858, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. X. Su, J. Wang, W. Chen, Z. Li, X. Fu, and A. Yang, “Overexpression of TRIM14 promotes tongue squamous cell carcinoma aggressiveness by activating the NF-κB signaling pathway,” Oncotarget , vol. 7, no. 9, pp. 9939–9950, 2016. View at Publisher · View at Google Scholar · View at Scopus